Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1991 Apr;82(4):426–432. doi: 10.1111/j.1349-7006.1991.tb01866.x

Four Forms of Cytochrome P‐450 in Human Fetal Liver: Purification and Their Capacity to Activate Promutagens

Mitsukazu Kitada 1,†, Masaki Taneda 1, Koshiro Itahashi 2, Tetsuya Kamataki 1
PMCID: PMC5918441  PMID: 1904422

Abstract

Four forms of cytochrome P‐450 were separated and purified to electrophoretic homogeneity from human fetal livers. These forms of cytochrome P‐450, termed P‐450HFLa, P‐450HFLb, P‐450HFLc and P‐450HFLd, were distinguishable from each other in their molecular weights, spectral properties, immunochemical properties and mutagen‐producing activities from promntagens. The molecular weights of P‐450HFLa, b, c and d were estimated to be 51,500, 49,000, 51,500 and 50,000, respectively. Antibodies to P‐450HFLa recognized P‐450HFLc but not P‐450HFLb or d, and antibodies to rat P‐448‐H (P‐450IA2) cross‐reacted with P‐450HFLb but not with other forms of cytochrome P‐450. The N‐terminal amino acid sequence of P‐450HFLc was highly homologous, but not identical, to that of P‐450HFLa. Each form of cytochrome P‐450 catalyzed mutagenic activation of aflatoxin Bl (AFB1), 2‐amino‐3‐methylimidazo[4,5‐f]quinoline (IQ) and 2‐amino‐6‐methyldipyrido‐[l,2‐a:3′,2′‐d]imidazole (Glu‐P‐1) at different rates. P‐450 HFLa showed activities to produce mutagen(s) from AFB1, IQ and to a lesser extent from Glu‐P‐1. P‐450 HFLb activated IQ at a faster rate than did the other forms. P‐450 HFLc produced a mutagen from AFB1 and Glu‐P‐1 but not from IQ. P‐450 HFLd did not activate these promutagens at significant rates.

Keywords: Human fetal liver, Cytochrome P‐450, Purification, Promutagens

Full Text

The Full Text of this article is available as a PDF (424.6 KB).

In the present study, the apparent molecular weight of P‐450 HFLa was estimated to be 51,500 rather than 51.0006) when bovine serum albumin, catalase and aldolase were used as the standard proteins and when the mobility of P‐450 HFLa was compared to that of P‐450NF.33) We therefore wish to revise the molecular weight of P‐450 HFLa to 51,500.

REFERENCES

  • 1. ) Yaffe , S. J. , Rane , A. , Sjoqvist , F. , Boreus , O. and Orrenius , S.The presence of a monoosygenase system in human fetal liver microsomes . Life Sci. , 9 , 1189 – 1200 ( 1970. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Juchau , M. R. , Chao , S. T. and Omiecinski , C. J.Drug metabolism by the human fetus . Clin. Pharmacokinet. , 5 , 320 – 339 ( 1980. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Pelkonen , O.Transplacental transfer of foreign compounds and their metabolism by the fetus . Prog. Drug Metabo. , 2 , 119 – 161 ( 1977. ). [Google Scholar]
  • 4. ) Jones , A. H. , Fantel , A. G. , Kocan , R. A. and Juchau , M. R.Bioactivation of procarcinogens to mutagens in human fetal and placental tissues . Life Sci. , 21 , 1831 – 1836 ( 1977. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Kitada , M. , Taneda , M. , Ohi , H. , Komori , M. , Itahashi , K. , Nagao , M. and Kamataki , T.Mutagenic activation of aflatoxin Bl by P‐450 HFLa in human fetal livers . Mutat. Res. , 227 , 53 – 58 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Kitada , M. , Kamataki , T. , Itahashi , K. , Rikihisa , T. , Kato , R. and Kanakubo , Y.Purification and properties of cytochrome P‐450 from homogenates of human fetal livers . Arch. Biochem. Biophys. , 241 , 275 – 280 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Shimada , T. and Nakamura , S.Cytochrome P‐450‐mediated activation of procarcinogens and promutagens to DNA‐damaging products by measuring expression of umu géne in Salmonella typhimurium TA1535/pSK1002 . Biochem. Pharmacol , 36 , 1979 – 1987 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Omura , T. and Sato , R.The carbon monoxide‐binding pigment of liver microsomes I. Evidence for its hemoprotein nature . J. Biol Chem. , 239 , 2370 – 2378 ( 1964. ). [PubMed] [Google Scholar]
  • 9. ) Kamataki , T. , Maeda , K. , Yamazoe , Y. , Matsuda , N. , Ishii , K. and Kato , R.A high‐spin form of cytochrome P‐450 highly purified from polychlorinated biphenyl‐treated rats – catalytic characterization and immunochemical quantitation in liver microsomes . Mol. Pharmacol. , 24 , 146 – 155 ( 1983. ). [PubMed] [Google Scholar]
  • 10. ) Imai , Y.The use of 8‐aminooctyl Sepharose for the separation of some components of the hepatic microsomal electron transfer system . J. Biochem. , 80 , 267 – 276 ( 1976. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Yasukochi , Y. and Masters , B. S. S.Some properties of a detergent‐solubilized NADPH‐cytochrome c (cytochrome P‐450) reductase purified by biospeciflc affinity chromatography . J. Biol. Chem. , 251 , 5337 – 5344 ( 1976. ). [PubMed] [Google Scholar]
  • 12. ) Phillips , A. H. and Langdon , R. G.Hepatic triphosphopyridine nucleotide‐cytochrome c reductase; isolation, characterization, and kinetic studies . J. Biol. Chem. , 237 , 2652 – 2660 ( 1962. ). [PubMed] [Google Scholar]
  • 13. ) Kamataki , T. , Belcher , D. H. and Neal , R. A.Studies of the metabolism of diethyl p‐nitrophenyl phosphorothionate (parathion) and benzphetamine using an apparently homogeneous preparation of rat liver cytochrome P‐450: effect of a cytochrome P‐450 antibodies preparation . Mol. Pharmacol , 12 , 921 – 932 ( 1976. ). [PubMed] [Google Scholar]
  • 14. ) Laemmli , U. K.Cleavage of structure proteins during the assembly of the head of bacteriophage T4 . Nature , 227 , 680 – 685 ( 1970. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Guengerich , F. P. , Wang , P. and Davidson , N. K.Estimation of isozymes of microsomal cytochrome P‐450 in rats, rabbits, and human using immunochemical staining coupled with sodium dodecylsulfate‐polyacrylamide gel electrophoresis . Biochemistry , 21 , 1698 – 1706 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Lowry , O. H. , Rosebrough , H. J. , Farr , A. L. and Randall , R. J.Protein measurement with the Folin phenol reagent . J. Biol Chem. , 193 , 265 – 275 ( 1951. ). [PubMed] [Google Scholar]
  • 17. ) Cresteil , J. , Beaune , P. , Kremers , P. , Flinois , J‐P. and Leroux , J‐P.Drug‐metabolizing enzymes in human foetal liver: partial resolution of multiple cytochrome P‐450 . Pediatr. Pharmacol. , 2 , 199 – 207 ( 1982. ). [PubMed] [Google Scholar]
  • 18. ) Komori , M. , Nishio , K. , Ohi , H. , Kitada , M. and Kamataki , T.Molecular cloning and sequence analysis of cDNA containing entire coding region for human fetal liver cytochrome P‐450 . J. Biochem. , 105 , 161 – 163 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Beaune , P. H. , Umbenhauer , D. R. , Bork , R. W. , Lloyd , R. S. and Guengerich , F. P.Isolation and sequence determination of a cDNA clone related to human cytochrome P‐450 nefedipine oxidase . Proc. Nail. Acad. Sci. USA , 83 , 8064 – 8068 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. ) Molowa , D. T. , Schuets , E. Z. , Wrighton , S. A. , Watkins , P. B. , Kremers , P. , Mendez‐Picon , G. , Parker , G. A. and Guzelian , P. S.Complete cDNA sequence of a cytochrome P‐450 inducible by glucocorticoids in human liver . Proc. Natl. Acad. Sci. USA , 83 , 5311 – 5315 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Kitada , M. , Kamataki , T. , Itahashi , K. , Rikihisa , T. and Kanakubo , Y.Significance of cytochrome P‐450 (P‐450 HFLa) of human fetal livers in the steroid and drug oxidations . Biochem. Pharmacol , 36 , 453 – 456 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Komori , M. , Nishio , K. , Kitada , M. , Shiramatsu , K. , Muroya , K. , Soma , M. , Nagashima , K , and Kamataki , T.Fetus‐specific expression of a form of cytochrome P‐450 in human fetal livers . Biochemistry , 29 , 4430 – 4433 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Kitada , M. , Taneda , M. , Ohta , K. , Nagashima , K. , Itahashi , K. and Kamataki , T.Metabolic activation of aflatoxin Bl and 2‐amino‐3‐methylimidazo[4,5‐f]quinoline by human adult and fetal livers . Cancer Res. , 50 , 2641 – 2645 ( 1990. ). [PubMed] [Google Scholar]
  • 24. ) Wrighton , S. A. , Campanile , C. , Thomas , P. E. , Maines , S. L.Watkins , P. B. , Parker , G. , Mendez‐Picon , G. , Haniu , M. , Shively , J. E. , Levin , W. and Guzelian , P. S.Identification of a human liver cytochrome P‐450 homologous to the major isosafrole‐inducible cytochrome P‐450 in the rat . Mol. Pharmacol , 29 , 405 – 410 ( 1986. ). [PubMed] [Google Scholar]
  • 25. ) Yamazoe , Y. , Abu‐Zeid , M. , Yamauchi , K. and Kato , R.Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P‐448‐H type cytochrome P‐450 . Jpn. J. Cancer Res. , 79 , 1159 – 1167 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Ohta , H. , Kitada , M. , Ohi , H. , Komori , M. , Nagashima , K. , Sato , N. , Moroya , K. , Kodama , J. , Nagao , M. and Kamataki , T.Interspecies homology of cytochrome P‐450; toxicological significance of cytochrome P‐450 crossreactive with anti‐rat P448‐H antibodies in liver microsomes from dogs, monkeys and humans , Mutat. Res. , 226 , 163 – 167 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Aoyama , T. , Gonzalez , F. J. and Gelboin , H. V.Human cDNA‐expressed cytochrome P‐450IA2: mutagen activation and substrate specificity . Mol. Carcinog. , 2 , 192 – 198 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Distlerath , L. M. , Reilly , P. E. B. , Martin , M. V. , Davis , G. G. , Wilkinson , G. R. and Guengerich , F. P.Purification and characterization of the human liver cytochrome P‐450 involved in debrisoquine 4‐hydroxylation and phenacetin O‐deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism , J. Biol. Chem. , 260 , 9057 – 9067 ( 1985. ). [PubMed] [Google Scholar]
  • 29. ) Shimada , T. , Iwasaki , M. , Martin , M. V. and Guengerich , F. P.Human liver microsomal cytochrome P‐450 enzymes involved in the bioactivation of promutagens detectd by umu gene response in Salmonella typhimurium TA1535/ PSK1002 , Cancer Res. , 49 , 3218 – 3228 ( 1989. ). [PubMed] [Google Scholar]
  • 30. ) Omiecinski , C. J. , Redlich , C. A. and Costa , P.Induction and developmental expression of cytochrome P‐450 IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction . Cancer Res. , 50 , 4315 – 4321 ( 1990. ). [PubMed] [Google Scholar]
  • 31. ) Wrighton , S. A. and Vandenbranden , M.Isolation and characterization of human fetal liver cytochrome P‐450 HLp2: a third member of the P‐450III gene family . Arch. Biochem. Biophys. , 268 , 144 – 151 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Kawano , S. , Kamataki , T. , Yasumori , T. , Yamazoe , Y. and Kato , R.Purification of human liver cytochrome P‐450 catalyzing testosterone 6β‐hydroxylation . J. Biochem. , 102 , 493 – 501 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Guengerich , F. P. , Martin , M. V. , Beaune , P. H. , Kremers , P. , Wolff , T. and Waxman , D. J.Characterization of rat and human liver microsomal cytochrome P‐450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism . J. Biol. Chem. , 261 , 5051 – 5060 ( 1986. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES